Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry, v3.5.2, appears in the history, replacing v3.5.0. The update records the page version change rather than altering study information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision entry v3.5.0 to the history and removed the v3.4.3 entry.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry has been added to the record history, documenting an update to the study status.SummaryDifference0.1%

- Check74 days agoChange DetectedThe revision adds results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with updated documentation. It also updates Study Status and other study data sections.SummaryDifference2%

- Check81 days agoChange DetectedAdded a site-wide notice about funding and operating status. Updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.6%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.